Table 2 Baseline characteristics of the study population
End-stage renal disease | Population Controls | P | |
|---|---|---|---|
Number of participants | 12,293 | 229,524 | - |
Male sex, n (%) | 7,683 (62.5) | 143,622 (62.6) | 0.9 |
Age at indexdatea, n (%) | |||
14-49 | 3,516 (28.6) | 64,464 (28.1) | 0.5 |
50-64 | 3,630 (29.5) | 68,413 (29.8) | |
≥65 | 5,147 (41.9) | 96,647 (42.1) | |
Comorbidity level at indexdateb | |||
Low | 4,231 (34.4) | 169,330 (73.8) | <0.001 |
Medium | 3,663 (29.8) | 46,539 (20.3) | |
High | 4,399 (35.8) | 13,655 (6.0) | |
Cause of end-stage renal disease | |||
Glomerulonephritis | 1,751 (14.2) | - | NA |
Diabetes I + II | 2,595 (21.1) | - | |
Chronic interstitial nephritis | 1,496 (12.2) | - | |
Hypertension and Chronic renal | |||
failure without specification | 4,019 (32.7) | - | |
Adult polycystic kidney disease | 969 (7.9) | - | |
Vasculitis | 438 (3.6) | - | |
Other | 1,025 (8.3) | - | |
Transplant history | |||
No transplantation | 8,978 (73.0) | - | NA |
≥1 Transplantation | 3,315 (27.0) | - |